title: [Venous thrombolysis with the recombinant human tissue-type plasminogen activator (rt-PA) during the first 3 hours following acute myocardial infarction. Controlled pilot study with placebo].
authors.forename: G
authors.initials: G
authors.lastname: Melandri
authors.forename: A
authors.initials: A
authors.lastname: Branzi
authors.forename: C
authors.initials: C
authors.lastname: Berardi
authors.forename: F
authors.initials: F
authors.lastname: Bruscoli
authors.forename: F
authors.initials: F
authors.lastname: Tartagni
authors.forename: G
authors.initials: G
authors.lastname: Binetti
authors.forename: N
authors.initials: N
authors.lastname: Galiè
authors.forename: B
authors.initials: B
authors.lastname: Magnani
authors.forename: G F
authors.initials: GF
authors.lastname: Gensini
authors.forename: R
authors.initials: R
authors.lastname: Abbate
mesh_terms: D000368:Aged; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy*; D010865:Pilot Projects; D010919:Placebos; D010960:Plasminogen Activators / Q000009:adverse effects / Q000627:therapeutic use*; D013318:Stroke Volume / Q000187:drug effects
chemical_list: D005343:Fibrinolytic Agents; D010919:Placebos; D010960:Plasminogen Activators
vernacular_title: Trombolisi per via venosa mediante l'attivatore tissutale umano ricombinante del plasminogeno (rt-PA) nelle prime tre ore dell'infarto miocardico acuto. Studio pilota controllato con placebo.